Get the Stockscreener App
5.90
5.90%
-0.37
Pre-market:
5.59
-0.31
-5.25%
Tenax Therapeutics Inc Stock (TENX) Latest News
Tenax Therapeutics appoints new VP of Clinical Operations - MSN
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
How the (TENX) price action is used to our Advantage - Stock Traders Daily
Leerink Partnrs Weighs in on TENX FY2029 Earnings - Defense World
David Risinger Recommends Buy for Tenax Therapeutics Amid Promising Phase 3 Trials and Growth Potential - TipRanks
Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewswire
Exclusive: Tenax CEO to Reveal Latest Cardiovascular Drug Pipeline Updates at Major Biotech Conference - StockTitan
Trump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health Care - Benzinga
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Tenax Therapeutics Appoints Gillian Andor Vice President, Clinical Operations - The Manila Times
Analysts Set Tenax Therapeutics, Inc. (NASDAQ:TENX) Target Price at $16.00 - Defense World
PH balance: Tenax outweighs pharmas with levosimendan heart bid - BioWorld Online
Tenax Therapeutics (NASDAQ:TENX) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Comparing Merus (NASDAQ:MRUS) & Tenax Therapeutics (NASDAQ:TENX) - Defense World
Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives $16.00 Consensus Target Price from Analysts - Defense World
Tenax Therapeutics, Inc. Appoints Thomas A. McGauley as Principal Financial Officer and Principal Accounting Officer - Marketscreener.com
Biotech Soars Following Oversubscribed $100M Private Placement Announcement - MSN
Will Tenax Therapeutics (NASDAQ:TENX) Spend Its Cash Wisely? - Yahoo Finance
Is Tenax Therapeutics (NASDAQ:TENX) In A Good Position To Invest In Growth? - Simply Wall St
Tenax Therapeutics Appoints Interim CFO Thomas McGauley - TipRanks
Tenax Therapeutics: Q3 Earnings Snapshot - New Haven Register
Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - The Manila Times
Tenax Therapeutics Secures $100M Funding, Extends Runway to 2027 Despite Wider Q3 Loss | TENX Stock News - StockTitan
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation Conference - The Manila Times
Tenax Therapeutics expands stock incentive plan By Investing.com - Investing.com Australia
Tenax Therapeutics expands stock incentive plan - Investing.com
Tenax Therapeutics Expands Stock Incentive Plan - TipRanks
Analysts Set Tenax Therapeutics, Inc. (NASDAQ:TENX) Target Price at $170.67 - Defense World
FY2024 Earnings Estimate for TENX Issued By Leerink Partnrs - Defense World
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at Leerink Partners - Defense World
Leerink Partnrs Upgrades Tenax Therapeutics (NASDAQ:TENX) to “Strong-Buy” - Defense World
This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Warning: TENX is at high risk of performing badly - MSN
Guggenheim Initiates Coverage of Tenax Therapeutics (TENX) with Buy Recommendation - Nasdaq
Tenax Therapeutics, Inc. to Post Q3 2024 Earnings of ($1.50) Per Share, William Blair Forecasts (NASDAQ:TENX) - Defense World
William Blair Initiates Coverage of Tenax Therapeutics (TENX) with Outperform Recommendation - MSN
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):